You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
McKinsey
Express Scripts
Baxter
Boehringer Ingelheim

Last Updated: February 26, 2020

DrugPatentWatch Database Preview

Drug Sales Trends for SEVELAMER


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Payment Methods and Pharmacy Types for SEVELAMER (2017)

Revenues by Pharmacy Type

Pharmacy Type Revenues
DRUG STORE $66,072,227
[disabled in preview] $0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
DRUG STORE 51,998
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICARE $66,072,227
[disabled in preview] $0
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for SEVELAMER
Drug Units Sold Trends for SEVELAMER

Annual Sales Revenues and Units Sold for SEVELAMER

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
SEVELAMER   Start Trial   Start Trial 2017
SEVELAMER   Start Trial   Start Trial 2016
SEVELAMER   Start Trial   Start Trial 2015
SEVELAMER   Start Trial   Start Trial 2014
SEVELAMER   Start Trial   Start Trial 2013
SEVELAMER   Start Trial   Start Trial 2012
>Drug Name >Revenues (USD) >Units >Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
McKesson
Colorcon
Express Scripts
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.